首页> 美国卫生研究院文献>Clinical Medicine >Refusal of viral testing during the SARS-CoV-2 pandemic
【2h】

Refusal of viral testing during the SARS-CoV-2 pandemic

机译:在SARS-COV-2大流行期间拒绝病毒检测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Widespread testing for the respiratory syndrome coronavirus-2 (SARS-CoV-2) will represent an important part of any strategy designed to safely reopen societies from lockdown. Healthcare settings have the potential to become reservoirs of infectivity, and therefore many hospital trusts are beginning to carry out routine screening of staff and patients. This could promote the effective cohorting of patients and reduce the rate of nosocomial infection. However, for various reasons, some individuals may refuse this testing. Here we highlight this as an emergent ethicolegal issue which we expect to become increasingly relevant as testing becomes ubiquitous. We explore this position from an ethical and legal perspective, determining whether refusal of testing is acceptable under UK law. Individual patients refusing testing could undermine a hospital's testing strategy; therefore clinicians and policy makers must prospectively determine the best course of action if this were to occur.
机译:对呼吸综合征Coronavirus-2(SARS-COV-2)的广泛测试将代表任何旨在安全地从锁定锁定社会的任何策略的重要组成部分。医疗保健设置有可能成为感染性的储层,因此许多医院信托都开始进行员工和患者的常规筛查。这可以促进患者的有效举办并降低医院感染率。但是,由于各种原因,一些人可能会拒绝这种测试。在这里,我们将其突出显示作为一种紧急的伦理学问题,我们预计随着测试变得越来越多地相关。我们从道德和法律角度探索这个职位,确定在英国法律下是否可以接受拒绝测试。拒绝测试的个体患者可能会破坏医院的测试策略;因此,临床医生和政策制定者必须先前确定最佳的行动方案,如果发生这种情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号